VB Spine Acquires Stryker’s Spinal Implants Business in Australia and New Zealand

Viscogliosi Brothers Acquires Stryker's U.S. Spine Business to Create VB Spine

April 1, 2025

Medical Devices

Viscogliosi Brothers, a New York–based family office, completed the acquisition of Stryker's U.S. spine business and will operate it as VB Spine, LLC. Financial partners Barings and Texas Capital Bank supported the transaction; VB Spine aims to grow the business, expand globally and retain access to Stryker technologies such as Mako Spine and Copilot.

VB Spine Acquires Stryker's Cestas Manufacturing Facility

January 6, 2026

Medical Devices

VB Spine LLC completed the acquisition of Stryker’s spinal implant manufacturing facility in Cestas, France, transferring site employees and operations to VB Spine. The deal expands VB Spine’s global manufacturing footprint and is financed in part by equity investors Viscogliosi Brothers entities with support from Barings.

Stryker Acquires Vertos Medical Inc.

August 22, 2024

Medical Devices

Stryker has entered into a definitive agreement to acquire Vertos Medical Inc., a privately held company that develops the minimally invasive Mild® procedure for treating lumbar spinal stenosis. The acquisition expands Stryker’s interventional pain management and minimally invasive treatment portfolio and extends its reach into ambulatory surgery centers; the transaction remains subject to customary closing conditions.

Spinal Simplicity Acquires Intralink‑Spine

May 6, 2022

Medical Devices

Spinal Simplicity, a Kansas‑based medical device company, acquired Intralink‑Spine and its injectable spinal disc stabilization technology. Spinal Simplicity said it will pursue regulatory paths to bring the technology to the U.S. and EU after promising initial pilot outcomes in Australia.

Nevro Corp. Acquires Vyrsa Technologies

November 30, 2023

Medical Devices

Nevro Corp. acquired Vyrsa Technologies, a privately held medical technology company focused on minimally invasive sacroiliac (SI) joint fusion devices, in a deal that closed November 30, 2023. Nevro paid $40 million at closing and may pay up to an additional $35 million in cash or stock tied to development and sales milestones; the company said Vyrsa will broaden its product portfolio and is projected to be accretive in 2024.

Stryker Acquires NICO Corporation

September 20, 2024

Medical Devices

Stryker has completed the acquisition of NICO Corporation, a privately held developer of minimally invasive neurosurgical systems including BrainPath and Myriad. The purchase expands Stryker's neurotechnology portfolio and strengthens its capabilities in tumor resection and treatment of intracerebral hemorrhage (stroke) worldwide.